ISMPP and Open Science – a perspective from Oxford PharmaGenesis
Our perspective Champion sponsor of the Annual Meeting Written by Chris Winchester, CEO, Oxford PharmaGenesis This year’s virtual Annual Meeting of ISMPP marked the end of my 3 years on the Board of Trustees, and a chance to reflect on our achievements in that time. As well as managing the transition from one extremely talented President…